Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure

Published:2017-09 Issue:8 Volume:20 Page:1025-1033
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Griffin Edward A.,Wonderling David,Ludman Andrew J.,Al-Mohammad Abdallah,Cowie Martin R.,Hardman Suzanna M.C.,McMurray John J.V.,Kendall Jason,Mitchell Polly,Shote Aminat,Dworzynski Katharina,Mant Jonathan

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference32 articles.

1. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study;Moe;Circulation,2007

2. National Heart Failure Audit. April 2012–March 2013;Cleland,2013

3. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure;Eichhorn;N Engl J Med,2001

4. Resource use and survival for patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician;Auerbach;Ann Intern Med,2000

5. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome;Rutten;Am Heart J,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in Heart Failure: From Research to Clinical Practice;Annals of Laboratory Medicine;2022-12-22

2. Economic Evaluation of an N-terminal Pro B-type Natriuretic Peptide-Supported Diagnostic Strategy Among Dyspneic Patients Suspected of Acute Heart Failure in the Emergency Department;The American Journal of Cardiology;2021-05

3. The Role of the Heart Failure Specialist: Benefits for Both the Patient and the Cardiology Community;ABC: Heart Failure & Cardiomyopathy;2021

4. Cardiovascular Risk Assessment for Noncardiac Surgery: Are We Ready for Biomarkers?;Journal of Cardiothoracic and Vascular Anesthesia;2020-07

5. A value proposition for natriuretic peptide measurement in the assessment of patients with suspected acute heart failure;Clinica Chimica Acta;2020-01